Polynovo Limited
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CALZF research report →
About the company
Polynovo Ltd. engages in the development of medical devices, utilizing the patented polymer technology NovoSorb. It focuses on biodegradable temporizing matrix (BTM) product.
- CEO
- Bruce Peatey
- IPO
- 2009
- Employees
- 301
- HQ
- Port Melbourne, VIC, AU
Price Chart
- Market Cap
- $428.32M
- P/E
- 68.53
- P/S
- 4.91
- P/B
- 8.14
- EV/EBITDA
- 95.43
- Div Yield
- 0.00%
- Gross Margin
- 32.31%
- Op Margin
- 1.98%
- Net Margin
- 7.16%
- ROE
- 11.87%
- ROIC
- 2.64%
- Revenue
- $127.24M · 23.31%
- Net Income
- $13.21M · 151.17%
- EPS
- $0.02 · 151.32%
- Op Income
- $4.48M
- FCF YoY
- -1471.88%
- 52W High
- $1.02
- 52W Low
- $0.55
- 50D MA
- $0.74
- 200D MA
- $0.75
- Beta
- 1.35
- Avg Volume
- 2.07K
Get TickerSpark's AI analysis on CALZF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our CALZF coverage
Recent articles, reports, and earnings notes.
No research on CALZF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate CALZF report →Similar companies
Peers in the same neighborhood.